Oncology Virtual Matchmaking Event

Expression of interest in virtual meetings

This survey aims to collect your partnering requests to be submitted to the companies listed below.

The final partnering meeting is subject to acceptance by the company you request, so please add as much information as possible about your company to help them make a decision.

The full description of comapnies is available at this address: http://www.cebr.net/oncology-profiles

You will be notified after the 20 January of acceptance of your meeting requests.

Your availability on 13/14th February will then be requested and meeting times confirmed

* indicates mandatory fields

Question Title

* 1. Company name

Question Title

* 2. Company address and website

Question Title

* 3. Name of partnering contact and e-mail address

Question Title

* 4. Preferred contact option (you can select both)

Skype (please provide skype ID)

Telephone (please provide direct telephone number)

Question Title

* 5. Company description (max 200 words)

Question Title

* 6. Please indicate here the companies you are interested in meeting

ABLE Biosciences. ABLE Biosciences is a CRO providing bioanalytical, analytical, biomarkers and proteomic services to customers as a key part of the drug and diagnostic development process.

Aldevron Freiburg GmbH. Rapidly generate custom-made antibodies starting from cDNA (core technology), protein or peptide against a wide range of targets.

Allosterix ltd. Allosterix offers first in class, highly specific TACE\ ADAM17 inhibitor for the treatment of EGFR related cancers. Allosterix also offer a drug design service for the design of highly specific, drugable inhibitor for every enzyme.

Almetis. Almetis design and develop anticancer metal-based molecules targeting the cell metabolism.

AlphaSzenszor Inc. Nanotube based electronic sensors for early detection and diagnosis of cancer using biomarkers in human breath.

Argon Pharma. ARGON PHARMA is a biotech company focused on the development of innovative therapies to combat cancer based in drug discovery of small molecules, and also in the development new technologies based on biodegradable polymers for drug delivery and diagnostic applications.

Astrid Research Kft. Astrid is one of the largest, privately held bioinformatics companies in Europe with offices in Austria and Hungary. Our focus is data management and analysis for genomics research by providing comprehensive IT solutions for diagnostic marker and therapeutic target identification.

Biognos AB. Biognos AB is focused on computational screening, both ligand-based (similarity searches) and structure-based (docking) using large databases of small molecules

BioMarCare Technologies Ltd. BioMarCare is a cancer diagnostics company developing blood and biopsy assays based on novel biomarker-panels for early detection, prognosis and monitoring of breast and colorectal malignancies.

Biomotif AB. Biomotif technology for: Conformational Epitope Mapping, Binding Site/Mode-of-action studies and Compound-Fishing-Epitope Imprinting affinity capture in the liquid phase.

ChemCon GmbH. ChemCon is the expert for inorganic and organic chemical R&D as well as small scale GMP API production, including high potents and legally controlled drugs.

EPHORAN MULTI IMAGING SOLUTIONS. EPHORAN Multi-Imaging Solutions, a CRO providing imaging expertise and knowledge for the application of imaging technologies in pre-clinical drug research and development.

GenIbet Biopharmaceuticals. GenIbet is a GMP manufacturing facility for Advanced Therapies (cell therapy, stem cells and gene therapy), as well as for bacterial products, in totally segregated and dedicated production areas.

iBET - Instituto de Biologia Experimental e Tecnológica. IBET is a private not for profit Portuguese biotechnology research organization created in 1989, where science and technology are used together to ensure the translational application of competences from early stage discovery to final production and processes.

IDD Therapeutics Ltd. IDD Therapeutics is engaged in development of anticancer drugs based on intelligent learning engine which enables design of multifunctional small molecules, for various potential biological targets for cancer, exhibiting potential superior safety and efficacy profiles compared to current therapies for a wide range of indications.

im3D S.p.A. im3D is an Italian company which designs, develops and markets medical workstations for supporting radiologists in the early diagnosis of cancer. Since 2010, im3D offers screening and corporate prevention services as well.

Intelligent Pharma. Intelligent Pharma is a service company specialized in computational chemistry and molecular modeling applied to drug discovery and development with experience in oncology research projects.

I-SEE. Internet-Simulation Evaluation Envision is a high tech start-up company operating in the field of Monte Carlo simulations and their application in oncologic field.

LEITAT - Biomed Division. Leitat’s Biomed Division discovers new therapeutic drugs and new diagnosis tools by means of its specialized technological platforms and strong expertise in oncology. The Biomed Division also fosters collaborations, partnerships and services with leading pharma and biotech companies and institutions.

LipoCure Ltd. Lipocure is an early stage pharmaceutical company with strong IP, developing; Injectable long circulating corticosteroid liposomes for acute inflammatory diseases, long circulating chemotherapy liposomes for various cancers and second generation long circulation Doxorubicin liposomes. Lipocure has established small aseptic production facility for nano-drugs production and plan to start first human study on 2012.

Pathology Diagnostics. Pathology Diagnostics Ltd is an independent GCLP accredited histopathology CRO delivering high quality tissue laboratory and diagnostics services to industry Research & Development scientists engaged in drug and biomarker development.

PROCELLTECH SRL. Procelltech's is a service provider for GMP-compliant Quality Control assays and for biological assays to characterize compounds in R&D phases.

Promec Elettronica SrL. Design & Production of "Electronical Devices"

ProQinase GmbH. By offering active recombinant kinases, biochemical kinase screenings, various cell-based assays and in vivo models, ProQinase is a leading preclinical service provider dedicated to support clients from academia, pharmaceutical and biotech industries in the development of novel therapies for cancer treatment

SATT Conectus Alsace

SOM Biotech. SOM Biotech, a drug reprofiling company using ligand based in silico technology.

Theradex (Europe) Ltd. Theradex is a full service niche clinical research organisation specialising in oncology research. The company has been in business for almost 30 years

TRANSGENE SA. Transgene is a fully integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases.

UROLEAD SAS. Urolead offers the best predictive way to test a drug candidate against cancer in the area of Prostate/Bladder or Kidney, by providing human tumour grafted on mice that can mimic human response

Comments